I agree with you...has global potential especially winning the lawsuit last year (in Europe) against Blue Sky (now with Smith and Nephew), currently its only wound competitor for "negative pressure therapy"...
if it gets its research and development going further with a strong growth factor supplement for wounds and/or has the potential to buy another company for expansion into other products, then I think it will go way higher....if it gets to 80s then it may go to 120s....
but perhaps you are right about shorting....even the "hedgers" love to short a company like this just to keep it down...
let me know if I can ever help with this board...
tsurge
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM